Porter R - Search Results

1

Why the hype about subtype? Bipolar I, bipolar II--it's simply bipolar, through and through!

Malhi GS, Byrow Y, Boyce P, Bassett D, Fitzgerald PB, Hopwood M, Lyndon W, Mulder R, Murray G, Singh A, Bryant R, Porter R. Malhi GS, et al. Among authors: porter r. Aust N Z J Psychiatry. 2016 Apr;50(4):303-6. doi: 10.1177/0004867416641541. Aust N Z J Psychiatry. 2016. PMID: 27005426 No abstract available.

2

Inadequate availability of pharmacological treatment for affective disorders in New Zealand.

Porter RJ, Mulder RT. Porter RJ, et al. N Z Med J. 2002 Feb 22;115(1148):78-81. N Z Med J. 2002. PMID: 11913939 Review.

3

PHARMAC and availability of pharmaceuticals.

Porter R, Mulder RT. Porter R, et al. N Z Med J. 2002 Jun 7;115(1155):274; author reply 274-5. N Z Med J. 2002. PMID: 12117167 No abstract available.

4

Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression.

Porter RJ, Mulder RT, Joyce PR. Porter RJ, et al. Psychopharmacology (Berl). 2003 Jan;165(3):216-21. doi: 10.1007/s00213-002-1282-0. Epub 2002 Nov 19. Psychopharmacology (Berl). 2003. PMID: 12439628 Clinical Trial.

5

The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.

Mulder RT, Porter RJ, Joyce PR. Mulder RT, et al. Among authors: porter rj. J Psychopharmacol. 2003 Mar;17(1):97-102. doi: 10.1177/0269881103017001711. J Psychopharmacol. 2003. PMID: 12680745 Clinical Trial.

6

Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation.

Porter R, Frampton C, Joyce PR, Mulder RT. Porter R, et al. Aust N Z J Psychiatry. 2003 Jun;37(3):257-64. doi: 10.1046/j.1440-1614.2003.01175.x. Aust N Z J Psychiatry. 2003. PMID: 12780462

7

Randomized controlled trials in psychiatry. Part II: their relationship to clinical practice.

Mulder RT, Frampton C, Joyce PR, Porter R. Mulder RT, et al. Among authors: porter r. Aust N Z J Psychiatry. 2003 Jun;37(3):265-9. doi: 10.1046/j.1440-1614.2003.01176.x. Aust N Z J Psychiatry. 2003. PMID: 12780463 Review.

8

Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms.

Joyce PR, Porter RJ, Mulder RT, Luty SE, McKenzie JM, Miller AL, Kennedy MA. Joyce PR, et al. Among authors: porter rj. Psychol Med. 2005 Apr;35(4):511-7. doi: 10.1017/s0033291704003861. Psychol Med. 2005. PMID: 15856721 Clinical Trial.

9

Tryptophan and tyrosine availability and response to antidepressant treatment in major depression.

Porter RJ, Mulder RT, Joyce PR, Luty SE. Porter RJ, et al. J Affect Disord. 2005 Jun;86(2-3):129-34. doi: 10.1016/j.jad.2004.11.006. J Affect Disord. 2005. PMID: 15935231 Clinical Trial.

10

PHARMAC and treatment of bipolar depression--the limits of utilitarianism.

Ellis P, Mulder R, Porter R. Ellis P, et al. Among authors: porter r. N Z Med J. 2006 Mar 31;119(1231):U1924. N Z Med J. 2006. PMID: 16582981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,148 results

Search Page

Filters